Author

Kenneth G. Hull

Baylor UniversityORCID 0000-0002-3697-9551Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Research Focus:drug response / drug discovery· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Daniel RomoiD· 2 shared Aaron Albee· 1 shared Agnès BassevilleiD· 1 shared Akshaya Ravichandran· 1 shared Amy W. KuiD· 1 shared Christopher B. DamociiD· 1 shared Christopher Nutter· 1 shared Diana V. MoralesiD· 1 shared

Activity by Year

2018-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Daniel RomoORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Combined HDAC and eIF4A inhibition: A novel epigenetic therapy for pancreatic adenocarcinoma

Maryam Safari, Luigi Scotto, Agnès Basseville, Thomas Litman, Haoran Xue, Lubov Petrukhin, Ping Zhou, Helen Elaine Remotti, Amy W. Ku, Diana V. Morales, Christopher B. Damoci, Mingzhao Zhu, Ravikanth Maddipati, Kenneth G. Hull, Robert W. Robey, , Susan Elaine Bates

This paper shows that combining HDAC and eIF4A inhibitors effectively treats pancreatic cancer by inducing epigenetic reprogramming and metabolic stress in preclinical models.

Drug Resistance Updates · Oct 5, 2025Peer-reviewedCancer Biology

Occidiofungin, an actin binding antifungal with in vivo efficacy in a vulvovaginal candidiasis infection

Akshaya Ravichandran, Mengxin Geng, Kenneth G. Hull, Daniel Romo, Shi-En Lu, Aaron Albee, Christopher Nutter, Donna M. Gordon, Mahmoud A. Ghannoum, Steve W. Lockless, Leif Smith

This paper identifies occidiofungin, a novel antifungal compound produced by Burkholderia contaminans, which targets actin and shows efficacy in treating vulvovaginal candidiasis in mice with reduced host toxicity.

bioRxiv · Jul 13, 2018 · PreprintMicrobiology